Asston Pharmaceuticals Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Asston Pharmaceuticals Ltd is ₹ 80 as of 06 May 15:30 . The p/e ratio of Asston Pharmaceuticals Ltd changed from 0 to 0 over 8 quarters. This represents a CAGR of 0.0% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 8 quarters. This represents a CAGR of -100.00% The market cap of Asston Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The revenue of Asston Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Procter & Gamble Health Ltd for the Sep '25 is ₹ 329.87 crore as compare to the Jun '25 revenue of ₹ 342.77 crore. This represent the decline of -3.76% The ebitda of Asston Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Procter & Gamble Health Ltd for the Sep '25 is ₹ 125.22 crore as compare to the Jun '25 ebitda of ₹ 94.37 crore. This represent the growth of 32.69% The net profit of Asston Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 88.54 crore over 6 quarters. This represents a CAGR of 53.49% The dividend payout of Asston Pharmaceuticals Ltd changed from 0 % to 0 % over 8 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 8 quarters. This represents a CAGR of -100.00% .

About Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
Limited' to contract produce pharmaceutical products for export market.
Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
Ferron Lifecare Private Limited, incorporated on 30th January 2020.
Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products. Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Asston Pharmaceuticals Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Asston Pharmaceuticals Ltd or Procter & Gamble Health Ltd?

Market cap of Asston Pharmaceuticals Ltd is 68 Cr while Market cap of Procter & Gamble Health Ltd is 8,566 Cr

What are the key factors driving the stock performance of Asston Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

The stock performance of Asston Pharmaceuticals Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Asston Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

As of May 6, 2026, the Asston Pharmaceuticals Ltd stock price is INR ₹80.0. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5160.9.

How do dividend payouts of Asston Pharmaceuticals Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Asston Pharmaceuticals Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.